September 2024 - D3VC August Investment Update: Deverra Therapeutics & EarthGrid

We are excited to share that D3VC has made two strategic investments in August, further expanding our portfolio in the healthcare and energy sectors. Below are the details of the companies we have added to our growing list of investments:

1. Deverra Therapeutics - Industry: Healthcare, Biotechnology, and Life Sciences. Website: deverratx.com. Deverra Therapeutics is at the forefront of revolutionizing immune cell therapies for cancer and other life-threatening illnesses. Their lead asset, Dilanubicel, has shown promising results, significantly improving remission rates in leukemia patients during a Phase 2 clinical trial. Deverra is now on the cusp of a pivotal trial that could lead to FDA approval, targeting the $3.5B+ global acute myeloid leukemia market. Deverra has been granted Fast Track designation, allowing them to expedite the development and review process with the FDA. We also spoke with Prevail Partners, the venture group leading Deverra's post-Crowdfund round. We were very impressed with their deep focus on life sciences, data-driven approach, and ability to expedite clinical trials toward FDA approval. Their strategic positioning includes potential license deals with major pharmaceutical companies, which enhances the investment's potential.

2. EarthGrid - Industry: Energy and Utilities. Website: earthgrid.io. EarthGrid is redefining infrastructure with Its vision of a global network of underground utility tunnels. These tunnels will carry clean energy, water, high-speed data, and e-commerce goods; all moved by a plasma-powered robot at a fraction of the cost and time of conventional methods. EarthGrid holds a patent for its plasma laser technology, a critical component of its innovative tunneling approach. The company currently has four purchase orders, with the first expected to close by the end of the year. This initial project will focus on underground wires, a significant step towards realizing their broader global vision of transforming infrastructure. EarthGrid's innovation has the potential to drastically reduce the environmental impact and cost of infrastructure development while also connecting underserved communities around the world.

These investments align perfectly with D3VC's mission to leverage AI and data science to identify and support early-stage companies with the potential to generate outsized returns. We are confident that these companies will play a significant role in transforming their respective industries.

A Positive Outlook on Venture Capital Returns.

A recent PitchBook study analyzed venture capital returns and reported an annualized return of 25.5%. We were pleased to see that this data conforms to our own predictions and supports our confidence in the potential of early-stage investing. You can go ahead and read that here.

Investment Crowdfunding: A Groundbreaking Financial Innovation.

We’re proud to share that Investopedia recently ranked investment crowdfunding as one of the 25 groundbreaking financial innovations from the past 25 years. This recognition highlights the significant impact that crowdfunding has had on democratizing access to capital and creating opportunities for early-stage companies. You can read more about this achievement here.

Seeking Introductions to Potential Investors.

As we continue to grow, we seek introductions to high-net-worth individuals, funds of funds investors, family offices, and others who might be interested in what we are doing at D3VC. We would greatly appreciate your referrals if you know anyone who would be a good fit. Please feel free to contact me directly at [email protected]. As always, thank you for your continued support. If you have any questions or would like to discuss these investments in more detail, please feel free to reach out.